Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07194395 · ClinicalTrials.gov registry record
Contactless Optical Monitoring of AV Access Using the PatenSee System in Outpatient Hemodialysis Patients
A clinical trial of Hemodialysis and Clinical Assessment, sponsored by PatenSee.
- Recruiting
- Registry status
- 90
- Enrollment target
- 2
- Study locations
NCT07194395 is a study of Hemodialysis and Clinical Assessment that is actively recruiting participants, run by PatenSee. The registered enrollment target is 90 participants, below the 131-participant average among 12 other Hemodialysis trials with a reported enrollment target (31% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT07194395, a study of Hemodialysis and Clinical Assessment, is actively recruiting participants, sponsored by PatenSee.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, non-interventional, single arm, international multicenter study in which up to 120 adult participants with kidney failure requiring regular hemodialysis through arteriovenous (AV) access (AV fistula or graft) will be recruited and evaluated using the PatenSee system. Data captured on the PatenSee system will be analyzed and evaluated against standard of care clinical monitoring of AV accesses.
Conditions Studied
Interventions
- DEVICE PatenSee System
Study Locations (2)
Michigan
- Henry Ford Hospital - Detroit
Hasharon
- Meir Medical Center - Kfar Saba
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-06-06 |
| Est. Completion | 2027-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07194395
The ClinicalTrials.gov registry entry for NCT07194395 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 131-participant average among 12 other Hemodialysis trials with a reported enrollment target (31% lower). The listed sponsor is PatenSee, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hemodialysis appearing as the primary indexed condition, and to 1 intervention - of which PatenSee System is the first listed.
NCT07194395 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Hasharon.
Frequently Asked Questions
What is clinical trial NCT07194395 about?
NCT07194395 is a clinical study titled "Contactless Optical Monitoring of AV Access Using the PatenSee System in Outpatient Hemodialysis Patients". This is a prospective, non-interventional, single arm, international multicenter study in which up to 120 adult participants with kidney failure requiring regular hemodialysis through arteriovenous (AV) access (AV fistula or graft) will be recruited and evaluated using the PatenSee system. Data cap...
What is the current status of trial NCT07194395?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2025-06-06. Estimated completion is 2027-02-28.
What conditions does trial NCT07194395 study?
This clinical trial studies the following conditions: Hemodialysis, Clinical Assessment.
What interventions are being tested in trial NCT07194395?
The interventions under investigation include: PatenSee System (DEVICE).
Who is sponsoring clinical trial NCT07194395?
This trial is sponsored by PatenSee, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07194395 being conducted?
This trial has 2 study locations across Michigan, Hasharon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemodialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physical Activity Prescription Program for Hemodialysis Patients
RECRUITING · NA
-
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
RECRUITING · NA
-
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
RECRUITING · Phase 2
-
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
RECRUITING · NA
-
Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans
ACTIVE NOT RECRUITING · NA
-
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.